<DOC>
	<DOCNO>NCT01683747</DOCNO>
	<brief_summary>The premise study enteral tranexamic acid help maintain small bowel integrity , often compromised critical illness due inadequate cardiovascular perfusion ( i.e. , shock ) , maintenance small bowel integrity decrease morbidity critically ill patient .</brief_summary>
	<brief_title>Single Dose Enteral Tranexamic Acid Critically Ill Patients</brief_title>
	<detailed_description>The primary objective study provide preliminary efficacy safety data enteral administration one-time dose tranexamic acid critically ill patient reduction morbidity 28 day enrollment study . Secondary objective study determine efficacy administration enteral tranexamic acid reduce intensive care unit ( ICU ) hospital length-of-stay , well mortality morbidity 6 month .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Critically ill patient admit ICU within 48 hour onset illness Patients feed tube ( e.g. , orogastric , nasogastric , PEG , etc . ) primary admit diagnosis cancer primary admit diagnosis acute congestive heart failure primary admit diagnosis chronic obstructive pulmonary disease ( COPD ) primary admit diagnosis acute myocardial infarction unstable cardiac arrythmia primary admit diagnosis amyotrophic lateral sclerosis ( ALS ) noninfectious disease primary admit diagnosis postoperative neurosurgical procedure know hypersensitivity tranexamic acid acquire disturbance color vision hematuria cause disease renal parenchyma active thromboembolic disease deep venous thrombosis pulmonary embolism patient know clot disorder know bleed disorder recent ( within 3 month ) active cerebrovascular bleed pregnancy inability take study medicine ( i.e. , ileus &gt; 500ml stomach residual , NPO status ) patient exclude discretion treat physician</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>sepsis</keyword>
	<keyword>shock</keyword>
	<keyword>placebo control</keyword>
	<keyword>double blind</keyword>
	<keyword>interventional</keyword>
</DOC>